QUANTITATIVE-ANALYSIS OF HCV RNA AND GENOTYPE IN PATIENTS
WITH CHRONIC HEPATITIS-C ACCOMPANIED BY ORAL LICHEN-PLANUS
Lichen planus (LP) is a common oral disorder
that may represent a mucosal reaction to a variety of factors,
including hepatitis C virus (HCV). To determine whether viral
factors play a role in oral lichen planus (OLP) pathogenesis, we
measured serum HCV RNA and determined HCV genotype in patients with
chronic hepatitis C accompanied by OLP. The subjects included 43
patients with chronic hepatitis C: 23 with OLP (group 1) and 20
without OLP (group 2). Serum was collected from all subjects and
used to quantify HCV RNA by the branched DNA signal amplification
assay; HCV genotypes were classified by the reverse
transcription-polymerase chain reaction (RT-PCR) method into types
I, II, III and IV. Comparison of patient characteristics disclosed
that the mean age of group 1, 60.7 years, was significantly higher
(P = 0.001) than that of group 2 (46.4 years). No significant
differences were seen between sexes in values of serum aspartate
aminotransferase (AST), alanine aminotransferase (ALT), total
protein (T protein), albumin and gamma-globulin. There were also no
significant differences in HCV RNA levels or HCV genotypes between
groups. The findings suggested that OLP pathogenesis was a result
of host factors rather than viral factors.
Authors: NAGAO Y, KURUME UNIV, SCH MED,
DEPT ORAL SURG, 67 ASAHIMACHI, KURUME FUKUOKA 830 EUROPEAN JOURNAL
OF CLINICAL INVESTIGATION 1996 JUN;26(6):495-498
Hep C and Fatty Liver Disease Linked
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease....
Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated...